Riedisheim, France

Sven Taylor

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Sure, I can help with that! Here's the article about inventor Sven Taylor:

Title: Sven Taylor: A Visionary Inventor in Sustainable Innovations

Introduction:

Sven Taylor, hailing from Riedisheim, FR, has carved a name for himself in the industry through his dedication to creating sustainable and impactful innovations. With a remarkable portfolio of 35 patents, Taylor’s work showcases his visionary approach to inventing.

Latest Patents:

1. Benzimidazole Derivatives: Taylor's latest patent involves compounds of formula (I), including pharmaceutically acceptable salts, which have applications in pharmaceutical compositions.

2. Cyclopentyl- and Cycloheptylpyrazoles: Another recent invention by Taylor, these novel derivatives have promising applications and are accompanied by physiologically acceptable salts.

Career Highlights:

Taylor has made significant contributions to notable companies such as Hoffmann-La Roche Inc. and Vernalis Research Limited, where he played a key role in driving innovation and research in the pharmaceutical industry.

Collaborations:

Throughout his career, Taylor has collaborated with esteemed colleagues, including Hans G. Richter and Jean-Marc Plancher. These collaborations have been instrumental in bringing his innovative concepts to life and making a lasting impact on the field.

Conclusion:

Sven Taylor's unwavering commitment to sustainable and impactful innovations, coupled with his extensive patent portfolio and collaborations with industry experts, solidifies his position as a visionary inventor in the industry. His contributions continue to shape the landscape of sustainable innovation, leaving a lasting legacy for future inventors to follow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…